Mutagenic bioassay of certain pharmacological drugs. I. Thiabendazole (TBZ).

Abstract

This report describes the chromosomal damage produced by 2-(4'-thiazolyl)benzimidazole or thiabendazole (TBZ) evaluated by "in vivo" and "in vitro" cytogenetic tests. The doses assayed in adult mice by the sister-chromatid exchange (SCE) and micronucleus tests were: 50, 100 and 200 mg/kg body weight; these are within the range of those used in human… (More)

Topics

  • Presentations referencing similar topics